Myriad Genetics Inc — Federal Contractor Profile
MYRIAD GENETICS INC: $25.6 Million in Federal Contracts with No Recent Activity
Contractor Overview
Total Contract Value: $25,632,612 ($25.6M)
Total Awards: 2
Company Profile
MYRIAD GENETICS INC is a federal contractor with a total government contract value of $25.6 million, spanning two contracts averaging $12.8 million each. The company has not secured any recent contracts, indicating a potential slowdown in new business. MYRIAD GENETICS INC specializes in genetic research and development, with a focus on genomics, biotechnology, and personalized medicine. Their core capabilities include genetic testing, data analysis, and the development of genetic-based therapies. The company has not disclosed any specific agency clients, suggesting a potentially diversified client base or a focus on niche projects. The lack of recent contracts and the absence of competitive or sole-source patterns indicate a cautious approach to securing new business. MYRIAD GENETICS INC has a track record of delivering on their projects, but the absence of notable projects and performance history makes it challenging to assess their long-term performance. The company's contract patterns suggest a strategy focused on maintaining existing relationships rather than aggressively seeking new contracts. Compared to industry peers, MYRIAD GENETICS INC appears to be a niche player in the biotechnology sector, with a focus on genetic research and development. The company's outlook is stable, with a focus on maintaining current contracts and potentially seeking niche projects in the future.
Specializations
- Genetic testing
- Genomics
- Biotechnology
- Personalized medicine
- Data analysis
- Therapy development
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: 0% competitive, 0% sole-source
Agency Concentration: N/A
Growth Trajectory: stable
Sole Source Rate: 0%
Recompete Rate: 100%
Competitive Position
MYRIAD GENETICS INC appears to be a niche player in the biotechnology sector, focusing on genetic research and development. The company's lack of competitive wins and sole-source contracts suggests a cautious approach to securing new business, potentially due to the specialized nature of their work. Their focus on maintaining existing relationships rather than aggressively seeking new contracts indicates a stable but potentially limited growth trajectory.
Value to Taxpayers
MYRIAD GENETICS INC provides specialized services in genetic research and development, which are critical for advancing medical knowledge and developing new therapies. However, the lack of recent contracts and the absence of competitive wins raise questions about the company's ability to deliver value for taxpayer money. The company's focus on maintaining existing relationships rather than aggressively seeking new contracts suggests a stable but potentially limited growth trajectory, which may impact the overall value provided to taxpayers.
Agency Relationships
MYRIAD GENETICS INC has not disclosed any specific agency clients, suggesting a potentially diversified client base or a focus on niche projects. The lack of agency concentration indicates a balanced approach to client relationships, but the absence of recent contracts and the absence of notable projects makes it challenging to assess the depth and breadth of their relationships with specific agencies.
Red Flags
- No recent contracts, indicating a potential slowdown in new business.
- No competitive wins, suggesting a cautious approach to securing new contracts.
- No sole-source contracts, which may indicate a lack of urgency in securing new business.
Green Flags
- Two contracts averaging $12.8 million each, indicating a significant level of government business.
- Focus on genetic research and development, which is critical for advancing medical knowledge and developing new therapies.
- No sole-source contracts, which may indicate a balanced approach to securing business through competition.
Key Contracts
MYRIAD GENETICS INC has secured two contracts with a total value of $25.6 million, averaging $12.8 million each. These contracts, while significant in size, do not provide specific details on the nature of the work or the agencies involved. The absence of recent contracts and the lack of competitive wins suggest that the company may be focusing on maintaining existing relationships rather than aggressively seeking new business. This approach may indicate a stable but potentially limited growth trajectory. The company's focus on genetic research and development, particularly in genomics and personalized medicine, suggests a strong commitment to advancing medical knowledge and developing new therapies. However, the lack of performance history and notable projects makes it challenging to assess the company's long-term performance and the value provided to taxpayers.
Frequently Asked Questions
What does MYRIAD GENETICS INC do for the federal government?
MYRIAD GENETICS INC specializes in genetic research and development, with a focus on genomics, biotechnology, and personalized medicine. The company provides genetic testing, data analysis, and the development of genetic-based therapies. Their core capabilities include genetic testing, genomics, biotechnology, personalized medicine, data analysis, and therapy development.
How much taxpayer money does MYRIAD GENETICS INC receive?
MYRIAD GENETICS INC has secured a total of $25.6 million in federal contracts, with an average contract size of $12.8 million. The company has not secured any recent contracts, indicating a potential slowdown in new business. The lack of competitive wins and sole-source contracts suggests a cautious approach to securing new business, potentially due to the specialized nature of their work.
Is MYRIAD GENETICS INC good value for taxpayer money?
MYRIAD GENETICS INC provides specialized services in genetic research and development, which are critical for advancing medical knowledge and developing new therapies. However, the lack of recent contracts and the absence of competitive wins raise questions about the company's ability to deliver value for taxpayer money. The company's focus on maintaining existing relationships rather than aggressively seeking new contracts suggests a stable but potentially limited growth trajectory, which may impact the overall value provided to taxpayers.
How does MYRIAD GENETICS INC win its contracts?
MYRIAD GENETICS INC has not secured any recent contracts, indicating a potential slowdown in new business. The company's lack of competitive wins and sole-source contracts suggests a cautious approach to securing new business, potentially due to the specialized nature of their work. Their focus on maintaining existing relationships rather than aggressively seeking new contracts indicates a stable but potentially limited growth trajectory.
What agencies use MYRIAD GENETICS INC most?
MYRIAD GENETICS INC has not disclosed any specific agency clients, suggesting a potentially diversified client base or a focus on niche projects. The lack of agency concentration indicates a balanced approach to client relationships, but the absence of recent contracts and the absence of notable projects makes it challenging to assess the depth and breadth of their relationships with specific agencies.
What are the risks of relying on MYRIAD GENETICS INC?
The lack of recent contracts and the absence of competitive wins raise concerns about the company's ability to secure new business. The company's focus on maintaining existing relationships rather than aggressively seeking new contracts suggests a stable but potentially limited growth trajectory. The absence of notable projects and performance history makes it challenging to assess the company's long-term performance and the value provided to taxpayers.
How does MYRIAD GENETICS INC compare to similar contractors?
MYRIAD GENETICS INC appears to be a niche player in the biotechnology sector, focusing on genetic research and development. The company's lack of competitive wins and sole-source contracts suggests a cautious approach to securing new business, potentially due to the specialized nature of their work. Their focus on maintaining existing relationships rather than aggressively seeking new contracts indicates a stable but potentially limited growth trajectory, which may impact their competitive position relative to industry peers.
Recent Federal Contracts
Myriad Genetics Inc has 1 federal contracts on record. Below are the largest awards:
| Contract | Agency | Amount | Type |
|---|---|---|---|
| NIH awards $12.8M contract to Myriad Genetics for proteomics-based therapeuti... | Department of Health and Human Services | $12.8M | N/A |